Fig. 2From: CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patientsKaplan–Meier plots of PFS for patients with sporadic EOC without BRCA1 methylation (BRCA1wt), EOC with mutations in HRD genes (BRCAmut) or sporadic EOC with BRCA1 methylation (BRCA1meth) stratified by KATNAL2 methylationBack to article page